{"id":"W2944150238","doi":"10.1016/j.jaip.2018.11.053","title":"The Challenges and Opportunities of Maximizing the Benefits of Severe Asthma Registries","year":2019,"lang":"en","type":"letter","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Novartis Pharmaceuticals Canada; Johnson and Johnson; AstraZeneca Canada; Teva Pharmaceutical Industries; Amgen Canada; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Asthma; Omalizumab; Context (archaeology); Dupilumab; Scopus; Allergy; Intensive care medicine; MEDLINE; Internal medicine; Immunology; Immunoglobulin E","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05430566,0.000737863,0.001744702,0.001681717,0.005718644,0.01473249,0.003535745,0.04951594,0.01441939],"category_scores_gemma":[0.1843746,0.001213472,0.001564419,0.001441259,0.01184146,0.02169216,0.008987824,0.04058143,0.005746981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005827005,"about_ca_system_score_gemma":0.01855572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005299411,"about_ca_topic_score_gemma":0.008094304,"domain_scores_codex":[0.9523863,0.02838356,0.004182245,0.002826299,0.008753132,0.003468519],"domain_scores_gemma":[0.6936802,0.2119059,0.01288376,0.007961148,0.02663043,0.04693853],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000187625,0.0002047843,0.00490016,0.000311161,0.00007140156,0.002884686,0.0007809131,0.0006303549,0.000401048,0.04919514,0.8781421,0.06229059],"study_design_scores_gemma":[0.0003484606,0.0002676038,0.005279658,0.001715394,0.00008476435,0.006474179,0.003604511,0.003170383,0.0002836167,0.1362356,0.8422416,0.0002941978],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0003478724,0.0007648906,0.0003261318,0.9951061,0.002065009,0.000005684385,0.00001186919,0.00001452234,0.001358],"genre_scores_gemma":[0.03002471,0.005545798,0.003948171,0.8785513,0.0782489,0.00009989259,0.00006007951,0.00006163096,0.003459671],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.05430566,"threshold_uncertainty_score":0.2871992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08309020409413598,"score_gpt":0.336630970701912,"score_spread":0.253540766607776,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}